Valencia Nutrition Limited (BOM:542910)
India · Delayed Price · Currency is INR 50.73
-7.67 (-13.13%)
At close: Aug 20, 2026
Valencia Nutrition Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 3.04 | 78.98 | 2.23 | 0.76 | 0.46 |
Cash & Short-Term Investments | 3.04 | 78.98 | 2.23 | 0.76 | 0.46 |
Cash Growth | -96.15% | 3441.61% | 195.36% | 65.57% | -82.95% |
Accounts Receivable | 84.75 | 64.8 | 9.7 | 2.92 | 0.58 |
Other Receivables | - | 0.23 | - | 6.16 | 6.16 |
Receivables | 131 | 133.17 | 23.64 | 9.08 | 6.74 |
Inventory | 134.39 | 26.59 | 6.96 | 8.36 | 0.78 |
Other Current Assets | 22.62 | 14.14 | 0.9 | 7.28 | 13.51 |
Total Current Assets | 291.06 | 252.88 | 33.72 | 25.47 | 21.49 |
Property, Plant & Equipment | 242.73 | 60.45 | 23.21 | 1.48 | 2.22 |
Long-Term Investments | 17.51 | 29.28 | - | - | - |
Other Intangible Assets | 22.76 | 1.44 | - | - | - |
Other Long-Term Assets | 0 | 0 | -0 | 0.89 | 0.77 |
Total Assets | 590.53 | 384.17 | 59.99 | 27.84 | 24.48 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 13.16 | 1.32 | 2.43 | 3.18 | 2.19 |
Accrued Expenses | 1.9 | 1.71 | 3.97 | 6.28 | 5.32 |
Other Current Liabilities | 2.19 | 0.46 | 20.71 | 3.23 | 5.02 |
Total Current Liabilities | 17.25 | 3.49 | 27.11 | 12.69 | 12.53 |
Long-Term Debt | 151.33 | 14.87 | 53.4 | 21.81 | 5.98 |
Other Long-Term Liabilities | 0 | 0 | - | 0 | 0 |
Total Liabilities | 168.58 | 18.36 | 80.5 | 34.5 | 18.51 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 183.2 | 169.8 | 55.85 | 55.85 | 55.85 |
Additional Paid-In Capital | - | 363.33 | 114.2 | 114.2 | 114.2 |
Retained Earnings | - | -179.82 | -190.56 | -176.71 | -164.09 |
Comprehensive Income & Other | 238.73 | 12.5 | - | - | - |
Total Common Equity | 421.94 | 365.81 | -20.51 | -6.66 | 5.97 |
Minority Interest | 0.02 | - | - | - | - |
Shareholders' Equity | 421.95 | 365.81 | -20.51 | -6.66 | 5.97 |
Total Liabilities & Equity | 590.53 | 384.17 | 59.99 | 27.84 | 24.48 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 151.33 | 14.87 | 53.4 | 21.81 | 5.98 |
Net Cash (Debt) | -148.29 | 64.11 | -51.17 | -21.05 | -5.52 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | - | 3.78 | -9.16 | -3.77 | -0.99 |
Filing Date Shares Outstanding | - | 16.98 | 13.96 | 5.59 | 5.59 |
Total Common Shares Outstanding | - | 16.98 | 5.59 | 5.59 | 5.59 |
Working Capital | 273.81 | 249.39 | 6.62 | 12.78 | 8.96 |
Book Value Per Share | - | 21.54 | -3.67 | -1.19 | 1.07 |
Tangible Book Value | 399.18 | 364.38 | -20.51 | -6.66 | 5.97 |
Tangible Book Value Per Share | - | 21.46 | -3.67 | -1.19 | 1.07 |
Land | - | 21.78 | 21.82 | - | - |
Buildings | - | 32.71 | - | - | - |
Machinery | - | 14.16 | 7.48 | 7.19 | 7.19 |